144 related articles for article (PubMed ID: 38646274)
1. Long-Term Survival of a Patient With Anaplastic Thyroid Carcinoma Treated With Hypofractionated Radiotherapy: A Case Report.
Tanaka M; Hatayama Y; Kawaguchi H; Fujioka I; Aoki M
Cureus; 2024 Mar; 16(3):e56689. PubMed ID: 38646274
[TBL] [Abstract][Full Text] [Related]
2. Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma.
Nachalon Y; Stern-Shavit S; Bachar G; Shvero J; Limon D; Popovtzer A
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1128-32. PubMed ID: 26512447
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated Radiotherapy Is Superior to Conventional Fractionation in an Orthotopic Model of Anaplastic Thyroid Cancer.
Oweida A; Phan A; Vancourt B; Robin T; Hararah MK; Bhatia S; Milner D; Lennon S; Pike L; Raben D; Haugen B; Pozdeyev N; Schweppe R; Karam SD
Thyroid; 2018 Jun; 28(6):739-747. PubMed ID: 29774792
[TBL] [Abstract][Full Text] [Related]
4. A multimodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients.
Busnardo B; Daniele O; Pelizzo MR; Mazzarotto R; Nacamulli D; Devido D; Mian C; Girelli ME
J Endocrinol Invest; 2000 Dec; 23(11):755-61. PubMed ID: 11194710
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated Radiotherapy for Anaplastic Thyroid Carcinoma: 15 Years of Experience in a Single Institution.
Takahashi N; Matsushita H; Umezawa R; Yamamoto T; Ishikawa Y; Katagiri Y; Tasaka S; Takeda K; Fukui K; Kadoya N; Ito K; Jingu K
Eur Thyroid J; 2019 Jan; 8(1):24-30. PubMed ID: 30800638
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.
Fan D; Ma J; Bell AC; Groen AH; Olsen KS; Lok BH; Leeman JE; Anderson E; Riaz N; McBride S; Ganly I; Shaha AR; Sherman EJ; Tsai CJ; Kang JJ; Lee NY
Cancer; 2020 Jan; 126(2):444-452. PubMed ID: 31593317
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial.
Sherman EJ; Harris J; Bible KC; Xia P; Ghossein RA; Chung CH; Riaz N; Gunn GB; Foote RL; Yom SS; Wong SJ; Koyfman SA; Dzeda MF; Clump DA; Khan SA; Shah MH; Redmond K; Torres-Saavedra PA; Le QT; Lee NY
Lancet Oncol; 2023 Feb; 24(2):175-186. PubMed ID: 36681089
[TBL] [Abstract][Full Text] [Related]
8. External beam radiation dose escalation for high grade glioma.
Khan L; Soliman H; Sahgal A; Perry J; Xu W; Tsao MN
Cochrane Database Syst Rev; 2020 May; 5(5):CD011475. PubMed ID: 32437039
[TBL] [Abstract][Full Text] [Related]
9. External beam radiotherapy for thyroid cancer: Patients, complications, and survival.
Goodsell K; Ermer J; Amjad W; Swisher-McClure S; Wachtel H
Am J Surg; 2023 Jun; 225(6):994-999. PubMed ID: 36707300
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated Radiotherapy for Anaplastic Thyroid Cancer: Systematic Review and Pooled Analysis.
Oliinyk D; Augustin T; Koehler VF; Rauch J; Belka C; Spitzweg C; Käsmann L
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32899355
[TBL] [Abstract][Full Text] [Related]
11. High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study.
Liu YE; Lin Q; Meng FJ; Chen XJ; Ren XC; Cao B; Wang N; Zong J; Peng Y; Ku YJ; Chen Y
Radiat Oncol; 2013 Aug; 8(1):198. PubMed ID: 23937855
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic thyroid carcinoma with rhabdomyoblastic differentiation: a case report with a good clinical outcome.
Olthof M; Persoon AC; Plukker JT; van der Wal JE; Links TP
Endocr Pathol; 2008; 19(1):62-5. PubMed ID: 18330722
[TBL] [Abstract][Full Text] [Related]
13. Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial.
Lin Q; Liu YE; Ren XC; Wang N; Chen XJ; Wang DY; Zong J; Peng Y; Guo ZJ; Hu J
Radiat Oncol; 2013 Aug; 8(1):201. PubMed ID: 23957889
[TBL] [Abstract][Full Text] [Related]
14. Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Report on two protocols. The Swedish Anaplastic Thyroid Cancer Group.
Tennvall J; Lundell G; Hallquist A; Wahlberg P; Wallin G; Tibblin S
Cancer; 1994 Aug; 74(4):1348-54. PubMed ID: 8055459
[TBL] [Abstract][Full Text] [Related]
15. Phase II evaluation of high dose accelerated radiotherapy for anaplastic thyroid carcinoma.
Mitchell G; Huddart R; Harmer C
Radiother Oncol; 1999 Jan; 50(1):33-8. PubMed ID: 10225555
[TBL] [Abstract][Full Text] [Related]
16. Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups.
Heron DE; Karimpour S; Grigsby PW
Am J Clin Oncol; 2002 Oct; 25(5):442-6. PubMed ID: 12393980
[TBL] [Abstract][Full Text] [Related]
17. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic thyroid cancer: outcomes of trimodal therapy.
Houlihan OA; Moore R; Jamaluddin MF; Sharifah A; Redmond HP; O'Reilly S; Feeley L; Sheahan P; Rock K
Rep Pract Oncol Radiother; 2021; 26(3):416-422. PubMed ID: 34277095
[TBL] [Abstract][Full Text] [Related]
19. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Dearnaley D; Syndikus I; Mossop H; Khoo V; Birtle A; Bloomfield D; Graham J; Kirkbride P; Logue J; Malik Z; Money-Kyrle J; O'Sullivan JM; Panades M; Parker C; Patterson H; Scrase C; Staffurth J; Stockdale A; Tremlett J; Bidmead M; Mayles H; Naismith O; South C; Gao A; Cruickshank C; Hassan S; Pugh J; Griffin C; Hall E;
Lancet Oncol; 2016 Aug; 17(8):1047-1060. PubMed ID: 27339115
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens.
Wang Y; Tsang R; Asa S; Dickson B; Arenovich T; Brierley J
Cancer; 2006 Oct; 107(8):1786-92. PubMed ID: 16967442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]